Instant Access

3-Hour Virtual Seminar on Handling OOS Test Results and Completing Robust Investigations

4995
Duration180 Minutes
Danielle DeLucy
Instructor

Danielle DeLucy

Pharmaceuticals, Biotechnology

View profile

This seminar will review the regulatory requirements for investigating an OOS Investigation. The responsibilities of the analyst, the supervisor and QA will be discussed. A detailed flow chart will be used to help the attendees clearly understand the steps and the order in which they are to be performed. The structure of an Investigation report which properly documents the investigation will be discussed.

The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters. Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.

Course Objectives:

• Learn the responsibilities of analysts and supervisors
• Listen to what the FDA looks for in terms of human errors
• Describe when a full investigation should be triggered
• Describe the frequency for re-testing and re-sampling
• Learn how to implement the corrective and preventive action plans (CAPA)

Course Outline:

Session 1:

Guidelines for Detecting an OOS or Atypical Result

• Definition Atypical or Out of Specification Result?
• Review of the FDA Guidance for Industry on Investigating OOS Test Results
          o Phase I: Initial Laboratory Investigation
          o Phase II: Full Scale Investigation
• Root Cause Analysis Methods
          o 5 Whys
          o Flow Charts
          o Checklists
          o Fishbone Diagrams

Session 2:

Testing the hypotheses regarding potential root causes

• Retesting
• Considering Other Batches

Session 3:

Developing a proper CAPA plan to address any Corrective Actions

• How to properly document findings
• Example of a proper OOS investigation write up

What You Get:

• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points

Who Will Benefit:

• Quality Assurance Departments
• Quality Control Departments
• Research and Development Departments
• Regulatory Affairs Departments
• Compliance Departments
• Laboratory Staff
• Training Departments
• GMP auditors
• Consultants

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : 3-Hour Virtual Seminar on Handling OOS Test Results and Completing Robust Investigations


Similar Trainings

6 Hours Virtual Seminar: Understanding and Controlling Biofilm - Preventing Water System Microbial Problems and Surviving Inspections
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 360 Minutes
View Program
Microbiological and Business Risk of not Testing Raw Materials for Microbial Presence
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 60 Minutes
View Program
Bioavailability and Bioequivalence Studies submitted in NDAs and INDs
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Veterinary Feed Directive (VFD) Final Rule – What you need to know?
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 60 Minutes
View Program
Packaging and Labeling for Commercial and Clinical Products
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program